Search

Your search keyword '"Chasco L"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Chasco L" Remove constraint Author: "Chasco L"
35 results on '"Chasco L"'

Search Results

1. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

2. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

3. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

4. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

5. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

6. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

7. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

8. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

9. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

10. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

11. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

12. OC 01.2 Oxygen vs Ambient Air in Patients with Intermediate-Risk Acute Pulmonary Embolism: The Air Randomized Clinical Trial

13. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

14. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

15. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

16. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

17. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

18. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

19. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

20. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

21. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

22. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

23. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

24. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

25. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

26. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

27. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

28. Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial.

29. Influence of physical activity on the prognosis of COPD patients: the HADO.2 score - health, activity, dyspnoea and obstruction.

30. Physical activity and sedentary behaviour in patients admitted with COPD: Associated factors.

31. Change in physical activity related to admission for exacerbation in COPD patients.

32. The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism.

33. Changes in health-related quality of life as a marker in the prognosis in COPD patients.

34. Thrombus in transit.

35. Predictive factors over time of health-related quality of life in COPD patients.

Catalog

Books, media, physical & digital resources